-
Teva reaches $225m Texas opioid settlement -
-
reduces stake Teva - Globes
-
Teva podría pagar $3.600 para resolver la disputa sobre los opioides
-
Teva CEO wanted to stay his job | The Times
-
Teva pharmaceuticals stock photography and images -
-
Teva to Develop Unique Wearable Tech Machine Learning Platform for Continuous Measurement & Analysis of Huntington Disease Symptoms in Collaboration with Intel - Huntington's Disease
-
Tags | Ctech
-
Teva Canada Charts New Prescription for Care Business
-
Teva reaches agreement with Oklahoma resolve state's claims - Pharmaceutical Business review
-
Teva Reaches Agreement With Settle the State's Price Fixing Claims
-
CSRWire - Teva Highlights Key in the 2017 Social Impact Report
-
Direct Relief, Teva Behavioral Health Access
-
Teva Up $703M of Global Women's Health Biz to CVC Capital | BioSpace
-
Teva Will Buy Maker of Migraine Patch Business -
-
challenged on possible breach EU antitrust rules
-
Berkovish & Web Design Studio.
-
- Wikiwand
-
Teva approval for asthma Cinqair | Pharmafile
-
Teva Stock Tase Fill Online, Printable, Fillable, Blank |
-
Teva Announces Appointment of New R&D Chief Officer
-
Launches Website Provide People Living With Huntington's Disease Information on Chorea
-
Just 10% employees located Israel - Globes
-
Teva Execs TASE's Earners List | Ctech
-
Teva Delists TASE, May - Hamodia.com
-
Israeli company Teva Pharmaceutical stocks drop nearly 18% The Jerusalem Post
-
Israel's Teva Partners With UK's Cancer Research Technology to Cancer Drugs | Jewish & Israel Algemeiner.com
-
Outrage as Teva charges $18,275 generic drug US - Jerusalem Post
-
Stock Price and Chart — TASE:TEVA —